Literature DB >> 17978019

Beta-amyloid modulation of synaptic transmission and plasticity.

Deepa V Venkitaramani1, Jeannie Chin, William J Netzer, Gunnar K Gouras, Sylvain Lesne, Roberto Malinow, Paul J Lombroso.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17978019      PMCID： PMC2671021          DOI： 10.1523/JNEUROSCI.3478-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  81 in total

1.  Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.

Authors:  W S Griffin; J G Sheng; J E McKenzie; M C Royston; S M Gentleman; R A Brumback; L C Cork; M R Del Bigio; G W Roberts; R E Mrak
Journal:  Neurobiol Aging       Date:  1998 Sep-Oct       Impact factor: 4.673

2.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

Authors:  R J Siarey; J Stoll; S I Rapoport; Z Galdzicki
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

4.  Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.

Authors:  James P Cleary; Dominic M Walsh; Jacki J Hofmeister; Ganesh M Shankar; Michael A Kuskowski; Dennis J Selkoe; Karen H Ashe
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

5.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice.

Authors:  N Kojima; H Ishibashi; K Obata; E R Kandel
Journal:  Learn Mem       Date:  1998 Nov-Dec       Impact factor: 2.460

7.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice.

Authors:  Y F Lu; N Kojima; K Tomizawa; A Moriwaki; M Matsushita; K Obata; H Matsui
Journal:  Eur J Neurosci       Date:  1999-01       Impact factor: 3.386

9.  A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.

Authors:  R M Escorihuela; A Fernández-Teruel; I F Vallina; C Baamonde; M A Lumbreras; M Dierssen; A Tobeña; J Flórez
Journal:  Neurosci Lett       Date:  1995-10-20       Impact factor: 3.046

Review 10.  Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

Authors:  A Vezzani; G Sperk; W F Colmers
Journal:  Trends Neurosci       Date:  1999-01       Impact factor: 13.837
View more
  56 in total

Review 1.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.

Authors:  Peter Penzes; Jon-Eric Vanleeuwen
Journal:  Brain Res Rev       Date:  2011-01-26

Review 2.  New views of Arc, a master regulator of synaptic plasticity.

Authors:  Jason D Shepherd; Mark F Bear
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 3.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

4.  Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.

Authors:  Pradeep Kurup; Yongfang Zhang; Jian Xu; Deepa V Venkitaramani; Vahram Haroutunian; Paul Greengard; Angus C Nairn; Paul J Lombroso
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

5.  A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Hiroaki Fukumoto; Hideki Takahashi; Naoki Tarui; Junji Matsui; Taisuke Tomita; Mitsuhiro Hirode; Masumi Sagayama; Ryouta Maeda; Makiko Kawamoto; Kazuko Hirai; Jun Terauchi; Yasufumi Sakura; Mitsuru Kakihana; Kaneyoshi Kato; Takeshi Iwatsubo; Masaomi Miyamoto
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 6.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

7.  Transient reduction of spontaneous neuronal network activity by sublethal amyloid beta (1-42) peptide concentrations.

Authors:  Philipp Görtz; Jessica Opatz; Mario Siebler; Susanne Aileen Funke; Dieter Willbold; Christian Lange-Asschenfeldt
Journal:  J Neural Transm (Vienna)       Date:  2009-02-13       Impact factor: 3.575

8.  Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression.

Authors:  Jan Lewerenz; Pamela Maher
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

Review 9.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.